Regentis Biomaterials Ltd. income statement RGNT
It recorded a net loss of $13.6 million. Diluted earnings per share were -$24.16.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
|---|---|
| Selling, general and administrative |
7
|
| Operating income |
-7
|
| Pretax income |
14
|
| Net income |
-14
|
| Basic EPS |
-24.16
|
| Diluted EPS |
-24.16
|
| Weighted average shares, basic |
1
|
| Weighted average shares, diluted |
1
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- RGNT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Or Akiva
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1912966
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.